U.S. Artificial Organs And Bionics Market (2025 - 2033) Size, Share & Trends Analysis Report By Product (Artificial Organs, Bionic), By Technology (Mechanical, Electronic) And Segment Forecasts

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation & Scope
                    1.2. Segment Definitions
                    1.3. Information Procurement
                        1.3.1. Purchased database
                        1.3.2. GVR’s internal database
                        1.3.3. Secondary sources
                        1.3.4. Primary research
                        1.3.5. Details of primary research
                    1.4. Information or Data Analysis
                        1.4.1. Data analysis models
                    1.5. Market Formulation & Validation
                    1.6. Model Details
                    1.7. List of Secondary Sources
                    1.8. List of Primary Sources
                    1.9. Objectives
Chapter 2. Executive Summary
                    2.1. Market Outlook
                    2.2. Segment Outlook
                        2.2.1. Product
                        2.2.2. Technology
                    2.3. Competitive Insights
Chapter 3. U.S. Artificial Organs and Bionic Market Variables, Trends & Scope
                    3.1. Market Lineage Outlook
                        3.1.1. Parent market outlook
                        3.1.2. Related/ancillary market outlook
                    3.2. Market Dynamics
                        3.2.1. Market driver analysis
                        3.2.2. Market restraint analysis
                    3.3. U.S. Artificial Organs and Bionic Market Analysis Tools
                        3.3.1. Industry Analysis - Porter’s
                            3.3.1.1. Supplier power
                            3.3.1.2. Buyer power
                            3.3.1.3. Substitution threat
                            3.3.1.4. Threat of new entrant
                            3.3.1.5. Competitive rivalry
                        3.3.2. PESTEL Analysis
                            3.3.2.1. Political landscape
                            3.3.2.2. Technological landscape
                            3.3.2.3. Economic landscape
                    3.4. U.S. Artificial Organs and Bionic Market: Pipeline Analysis
Chapter 4. U.S. Artificial Organs and Bionic Market: Product Estimates & Trend Analysis
                    4.1. Product Segment Dashboard
                    4.2. U.S. Artificial Organs and Bionic Market: Product Movement Analysis
                    4.3. U.S. Artificial Organs and Bionic Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Billion)
                    4.4. Artificial Organs
                        4.4.1. Market estimates and forecasts, 2021 to 2033 (USD Billion)
                            4.4.1.1. Kidney
                                4.4.1.1.1. Market estimates and forecasts, 2021 to 2033 (USD Billion)
                            4.4.1.2. Heart
                                4.4.1.2.1. Market estimates and forecasts, 2021 to 2033 (USD Billion)
                            4.4.1.3. Liver
                                4.4.1.3.1. Market estimates and forecasts, 2021 to 2033 (USD Billion)
                            4.4.1.4. Lungs
                                4.4.1.4.1. Market estimates and forecasts, 2021 to 2033 (USD Billion)
                            4.4.1.5. Pancreas
                                4.4.1.5.1. Market estimates and forecasts, 2021 to 2033 (USD Billion)
                    4.5. Bionics
                        4.5.1. Market estimates and forecasts, 2021 to 2033 (USD Billion)
                            4.5.1.1. Cochlear Implant
                                4.5.1.1.1. Market estimates and forecasts, 2021 to 2033 (USD Billion)
                            4.5.1.2. Exoskeleton
                                4.5.1.2.1. Market estimates and forecasts, 2021 to 2033 (USD Billion)
                            4.5.1.3. Bionic Limbs
                                4.5.1.3.1. Market estimates and forecasts, 2021 to 2033 (USD Billion)
                            4.5.1.4. Brain Bionic
                                4.5.1.4.1. Market estimates and forecasts, 2021 to 2033 (USD Billion)
                            4.5.1.5. Vision Bionic
                                4.5.1.5.1. Market estimates and forecasts, 2021 to 2033 (USD Billion)
Chapter 5. U.S. Artificial Organs and Bionic Market: Technology Estimates & Trend Analysis
                    5.1. Technology Segment Dashboard
                    5.2. U.S. Artificial Organs and Bionic Market: Technology Movement Analysis
                    5.3. U.S. Artificial Organs and Bionic Market Size & Trend Analysis, by Technology, 2021 to 2033 (USD Billion)
                    5.4. Mechanical
                        5.4.1. Market estimates and forecasts, 2021 to 2033 (USD Billion)
                    5.5. Electronic
                        5.5.1. Market estimates and forecasts, 2021 to 2033 (USD Billion)
Chapter 6. Competitive Landscape
                    6.1. Recent Developments & Impact Analysis, By Key Market Participants
                    6.2. Company/Competition Categorization
                    6.3. Vendor Landscape
                        6.3.1. Key company heat map analysis, 2024
                    6.4. Company Profiles
                        6.4.1. ABIOMED
                            6.4.1.1. Company overview
                            6.4.1.2. Financial performance
                            6.4.1.3. Product benchmarking
                            6.4.1.4. Strategic initiatives
                        6.4.2. Berlin Heart
                            6.4.2.1. Company overview
                            6.4.2.2. Financial performance
                            6.4.2.3. Product benchmarking
                            6.4.2.4. Strategic initiatives
                        6.4.3. SynCardia Systems, LLC
                            6.4.3.1. Company overview
                            6.4.3.2. Financial performance
                            6.4.3.3. Product benchmarking
                            6.4.3.4. Strategic initiatives
                        6.4.4. BiVACOR Inc.
                            6.4.4.1. Company overview
                            6.4.4.2. Financial performance
                            6.4.4.3. Product benchmarking
                            6.4.4.4. Strategic initiatives
                        6.4.5. Cochlear Ltd.
                            6.4.5.1. Company overview
                            6.4.5.2. Financial performance
                            6.4.5.3. Product benchmarking
                            6.4.5.4. Strategic initiatives
                        6.4.6. Ekso Bionics
                            6.4.6.1. Company overview
                            6.4.6.2. Financial performance
                            6.4.6.3. Product benchmarking
                            6.4.6.4. Strategic initiatives
                        6.4.7. Edwards Lifesciences Corporation
                            6.4.7.1. Company overview
                            6.4.7.2. Financial performance
                            6.4.7.3. Product benchmarking
                            6.4.7.4. Strategic initiatives
                        6.4.8. Boston Scientific Corporation
                            6.4.8.1. Company overview
                            6.4.8.2. Financial performance
                            6.4.8.3. Product benchmarking
                            6.4.8.4. Strategic initiatives
                        6.4.9. Jarvik Heart, Inc
                            6.4.9.1. Company overview
                            6.4.9.2. Financial performance
                            6.4.9.3. Product benchmarking
                            6.4.9.4. Strategic initiatives
                        6.4.10. Medtronic
                            6.4.10.1. Company overview
                            6.4.10.2. Financial performance
                            6.4.10.3. Product benchmarking
                            6.4.10.4. Strategic initiatives

List of Tables

Table 1 List of Abbreviations
Table 2 U.S. Artificial Organs and Bionic Market, 2021 - 2033 (USD Billion)
Table 3 U.S. Artificial Organs and Bionic Market, by Product, 2021 - 2033 (USD Billion)
Table 4 U.S. Artificial Organs and Bionic Market, by Technology, 2021 - 2033 (USD Billion)

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 QFD modeling for market share assessment
Fig. 6 Information Procurement
Fig. 7 Market Formulation and Validation
Fig. 8 Data Validating & Publishing
Fig. 9 Market Segmentation & Scope
Fig. 10 U.S. Artificial Organs and Bionic Market Snapshot
Fig. 11 Product Segment Snapshot
Fig. 12 Technology Segment Snapshot
Fig. 13 Competitive Landscape Snapshot
Fig. 14 Parent market outlook
Fig. 15 U.S. Artificial Organs and Bionic Market Value, 2024 (USD Billion)
Fig. 16 U.S. Artificial Organs and Bionic Market - Value Chain Analysis
Fig. 17 U.S. Artificial Organs and Bionic Market - Market Dynamics
Fig. 18 U.S. Artificial Organs and Bionic Market - PORTER’s Analysis
Fig. 19 U.S. Artificial Organs and Bionic Market - PESTEL Analysis
Fig. 20 U.S. Artificial Organs and Bionic Market Estimates & Forecasts, By Product: Key Takeaways
Fig. 21 U.S. Artificial Organs and Bionic Market Share, By Product, 2024 & 2033
Fig. 22 Artificial organ Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
Fig. 23 Kidney Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
Fig. 24 Heart Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
Fig. 25 Liver Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
Fig. 26 Lungs Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
Fig. 27 Pancreas Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
Fig. 28 Bionics Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
Fig. 29 Cochlear Implant Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
Fig. 30 Exoskeleton Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
Fig. 31 Bionic Limbs Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
Fig. 32 Brain Bionic Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
Fig. 33 Vision Bionic Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
Fig. 34 U.S. Artificial Organs and Bionic Market Estimates & Forecasts, By Technology: Key Takeaways
Fig. 35 U.S. Artificial Organs and Bionic Market Share, By Technology, 2024 & 2033
Fig. 36 Mechanical Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
Fig. 37 Electronic Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
Fig. 38 Key Company Categorization
Fig. 39 Company Market Positioning
Fig. 40 Strategy Mapping